No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients

Detalles Bibliográficos
Autores principales: Li, Feng, Zhao, Yi, Zhong, Ran, Cai, Xiuyu, Liu, Jun, He, Jianxing, Liang, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435392/
https://www.ncbi.nlm.nih.gov/pubmed/34584867
http://dx.doi.org/10.21037/tlcr-21-640
_version_ 1783751782531334144
author Li, Feng
Zhao, Yi
Zhong, Ran
Cai, Xiuyu
Liu, Jun
He, Jianxing
Liang, Wenhua
author_facet Li, Feng
Zhao, Yi
Zhong, Ran
Cai, Xiuyu
Liu, Jun
He, Jianxing
Liang, Wenhua
author_sort Li, Feng
collection PubMed
description
format Online
Article
Text
id pubmed-8435392
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-84353922021-09-27 No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients Li, Feng Zhao, Yi Zhong, Ran Cai, Xiuyu Liu, Jun He, Jianxing Liang, Wenhua Transl Lung Cancer Res Letter to the Editor AME Publishing Company 2021-08 /pmc/articles/PMC8435392/ /pubmed/34584867 http://dx.doi.org/10.21037/tlcr-21-640 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Letter to the Editor
Li, Feng
Zhao, Yi
Zhong, Ran
Cai, Xiuyu
Liu, Jun
He, Jianxing
Liang, Wenhua
No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
title No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
title_full No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
title_fullStr No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
title_full_unstemmed No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
title_short No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
title_sort no benefit of chemotherapy in osimertinib-treated postoperative non-small cell lung cancer patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435392/
https://www.ncbi.nlm.nih.gov/pubmed/34584867
http://dx.doi.org/10.21037/tlcr-21-640
work_keys_str_mv AT lifeng nobenefitofchemotherapyinosimertinibtreatedpostoperativenonsmallcelllungcancerpatients
AT zhaoyi nobenefitofchemotherapyinosimertinibtreatedpostoperativenonsmallcelllungcancerpatients
AT zhongran nobenefitofchemotherapyinosimertinibtreatedpostoperativenonsmallcelllungcancerpatients
AT caixiuyu nobenefitofchemotherapyinosimertinibtreatedpostoperativenonsmallcelllungcancerpatients
AT liujun nobenefitofchemotherapyinosimertinibtreatedpostoperativenonsmallcelllungcancerpatients
AT hejianxing nobenefitofchemotherapyinosimertinibtreatedpostoperativenonsmallcelllungcancerpatients
AT liangwenhua nobenefitofchemotherapyinosimertinibtreatedpostoperativenonsmallcelllungcancerpatients

Ejemplares similares